AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Glimiyes M 2mg/500mg Tablet SR

Prescription Icon
Prescription Required

Marketer

Pharvax Biosciences

Salt Composition

Glimepiride (2mg) + Metformin (500mg)

Overview Glimiyes M 2mg/500mg Tablet SR

Diabexe Duo 2mg/500mg extended-release tablets are classified as antidiabetic medications. This dual-action formulation treats type 2 diabetes in adults by managing blood glucose levels. Diabexe Duo should be ingested with meals, consistently at the same time daily for optimal efficacy. Dosage is determined and adjusted by your physician based on your blood sugar response. Continued use is crucial, even with controlled blood sugar, as abrupt cessation can elevate glucose levels, potentially causing kidney complications, vision impairment, neuropathy, and limb loss. This medication complements a comprehensive diabetes management plan, encompassing dietary adjustments, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications significantly impact diabetes control. Hypoglycemia (low blood sugar) is the most prevalent adverse effect, manifesting as sweating, dizziness, headache, or tremors. Regular meals and readily available glucose sources (e.g., sugary foods, fruit juice) are vital preventative measures. Alcohol consumption should be minimized due to its hypoglycemic potential. Other possible side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may occur in some individuals. This medication is contraindicated in type 1 diabetes, diabetic ketoacidosis, and severe hepatic or renal impairment. Individuals with a history of heart disease should inform their physician before commencing treatment. Pregnant or lactating women require medical consultation prior to use. Regular blood glucose monitoring and periodic blood tests (to assess blood cell counts and liver function) are recommended by your doctor.

Primary Ingredients of Glimiyes M 2mg/500mg Tablet SR

No text provided. Please provide the text you wish me to rephrase.

Uses of Glimiyes M 2mg/500mg Tablet SR

Managing type 2 diabetes

Major Benefits of Glimiyes M 2mg/500mg Tablet SR:

Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Glimiyes M 2mg/500mg Extended-Release Tablets should be administered with a meal.

Common Side effects of Glimiyes M 2mg/500mg Tablet SR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimiyes M 2mg/500mg Tablet SR:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Glimiyes M 2mg/500mg Tablet SR whole; do not break, crush, or chew it. Administer this medication with a meal.

How Glimiyes M 2mg/500mg Tablet SR works:

Glimiyes M 2mg/500mg Extended-Release tablets combine glimepiride and metformin, two agents that manage blood sugar. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood glucose. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose output, slowing intestinal glucose uptake, and enhancing insulin sensitivity.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimiyes M 2mg/500mg SR tablets with alcohol is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimiyes M 2mg/500mg SR tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing this medication. Seek medical advice before use.

Breast feedingBreast feedingUNSAFE

Extended-release Glimiyes M 2mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant harm from this medication.

DrivingDrivingCAUTION

Impaired driving is possible with both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.

KidneyKidneyCAUTION

For individuals with impaired kidney function, the use of Glimiyes M 2mg/500mg SR tablets requires careful consideration and potential dosage modification. Patients with severely compromised kidneys should avoid this medication. Close monitoring of kidney function is recommended during treatment. Consult your physician for guidance.

LiverLiverCAUTION

Patients with liver impairment should use Glimiyes M 2mg/500mg Tablet SR cautiously, potentially requiring dosage modification. Physician consultation is advised. For those with mild to moderate liver disease, initiate treatment with a low dose of Glimiyes M 2mg/500mg Tablet SR; however, its use is contraindicated in cases of severe liver disease.

What if you forget to take Glimiyes M 2mg/500mg Tablet SR :

Should you forget to take a Glimiyes M 2mg/500mg Tablet SR, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.

Facts to Know About Glimiyes M 2mg/500mg Tablet SR

LabelValue
Developing Habits No.
Treatment Category Diabetes Management

FAQs on Glimiyes M 2mg/500mg Tablet SR

Store this medication in its original, tightly closed container, following the storage instructions on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimiyes M 2mg/500mg Tablet SR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as Metformin-associated lactic acidosis or MALA). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume significant amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and bradycardia. If you experience any of these, discontinue Glimiyes M 2mg/500mg Tablet SR and seek immediate medical attention.
Glimiyes M 2mg/500mg SR tablets combine glimepiride and metformin to manage type 2 diabetes mellitus in adults. This combination improves blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and enhances insulin sensitivity. It's not suitable for type 1 diabetes.
Glimiyes M 2mg/500mg SR tablets may cause common side effects such as low blood sugar (hypoglycemia), taste changes, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects, including lactic acidosis, are also possible. Prolonged use may result in vitamin B12 deficiency.
Prolonged use of Glimiyes M 2mg/500mg Tablet SR can lead to vitamin B12 deficiency by hindering its absorption in the stomach. This deficiency, if left untreated, may result in anemia, neurological issues such as tingling, numbness in the extremities, weakness, urinary problems, cognitive changes, and balance difficulties (ataxia). To mitigate this risk, annual supplemental vitamin B12 intake is recommended by some researchers.
Glimiperide/metformin (Glimiyes M 2mg/500mg SR) can cause low blood sugar (hypoglycemia), characterized by symptoms such as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, and shakiness or anxiety. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other diabetes medications. Therefore, regular blood sugar monitoring is crucial. Always carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice.
Combining Glimiyes M 2mg/500mg SR tablets and alcohol is unsafe. Alcohol can lower blood sugar, risking hypoglycemia, and may also increase the risk of lactic acidosis.
Glimiyes M 2mg/500mg Tabl...
48
MRP 59
18% off